{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:55:37Z","timestamp":1791950137706,"version":"4.3.4"},"reference-count":59,"publisher":"Japanese Society of Toxicology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2022]]},"DOI":"10.2131\/jts.47.359","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T22:19:34Z","timestamp":1661984374000},"page":"359-373","source":"Crossref","is-referenced-by-count":10,"title":["Involvement of the CYP1A1 inhibition-mediated activation of aryl hydrocarbon receptor in drug-induced hepatotoxicity"],"prefix":"10.2131","volume":"47","author":[{"given":"Tomomi","family":"Yoda","sequence":"first","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."},{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Tochitani","sequence":"additional","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Usui","sequence":"additional","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Kouchi","sequence":"additional","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inada","sequence":"additional","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuomi","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Kanno","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izuru","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Preclinical Research Unit, Sumitomo Pharma Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bondy, S.C. and Naderi, S. (1994): Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem. Pharmacol., <b>48<\/b>, 155-159.","DOI":"10.1016\/0006-2952(94)90235-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Boverhof, D.R., Burgoon, L.D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J.R., Mendrick, D.L. and Zacharewski, T.R. (2006): Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL\/6 mice. Toxicol. Sci., <b>94<\/b>, 398-416.","DOI":"10.1093\/toxsci\/kfl100"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H. and Tong, W. (2011): FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov. Today, <b>16<\/b>, 697-703.","DOI":"10.1016\/j.drudis.2011.05.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chopra, M. and Schrenk, D. (2011): Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death. Crit. Rev. Toxicol., <b>41<\/b>, 292-320.","DOI":"10.3109\/10408444.2010.524635"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Dalton, T.P., Puga, A. and Shertzer, H.G. (2002): Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem. Biol. Interact., <b>141<\/b>, 77-95.","DOI":"10.1016\/S0009-2797(02)00067-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Dayan, A.D. (2003): Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop., <b>86<\/b>, 141-159.","DOI":"10.1016\/S0001-706X(03)00031-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Denison, M.S. and Nagy, S.R. (2003): Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol., <b>43<\/b>, 309-334.","DOI":"10.1146\/annurev.pharmtox.43.100901.135828"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Denison, M.S., Soshilov, A.A., He, G., DeGroot, D.E. and Zhao, B. (2011): Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci., <b>124<\/b>, 1-22.","DOI":"10.1093\/toxsci\/kfr218"},{"key":"9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2164-12-365","author":"E. Dere","year":"2011","unstructured":"Dere, E., Lo, R., Celius, T., Matthews, J. and Zacharewski, T.R. (2011): Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver. BMC Genomics, <b>12<\/b>, 365.","journal-title":"BMC Genomics","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2164","issn-type":"print"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Dewa, Y., Nishimura, J., Muguruma, M., Jin, M., Saegusa, Y., Okamura, T., Tasaki, M., Umemura, T. and Mitsumori, K. (2008): beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats. Toxicology, <b>244<\/b>, 179-189.","DOI":"10.1016\/j.tox.2007.11.010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Doan, T.Q., Connolly, L., Igout, A., Muller, M. and Scippo, M.L. (2020): In vitro differential responses of rat and human aryl hydrocarbon receptor to two distinct ligands and to different polyphenols. Environ. Pollut., <b>265<\/b> (Pt B), 114966.","DOI":"10.1016\/j.envpol.2020.114966"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M. and Gonzalez, F.J. (1996): Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-<i>p<\/i>-dioxin-induced toxicity. Toxicol. Appl. Pharmacol., <b>140<\/b>, 173-179.","DOI":"10.1006\/taap.1996.0210"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Goto, S., Deguchi, J., Nishio, N., Nomura, N. and Funabashi, H. (2015): Hepatotoxicants induce cytokine imbalance in response to innate immune system. J. Toxicol. Sci., <b>40<\/b>, 389-404.","DOI":"10.2131\/jts.40.389"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Harrill, J.A., Layko, D., Nyska, A., Hukkanen, R.R., Manno, R.A., Grassetti, A., Lawson, M., Martin, G., Budinsky, R.A., Rowlands, J.C. and Thomas, R.S. (2016): Aryl hydrocarbon receptor knockout rats are insensitive to the pathological effects of repeated oral exposure to 2,3,7,8-tetrachlorodibenzo-<i>p<\/i>-dioxin. J. Appl. Toxicol., <b>36<\/b>, 802-814.","DOI":"10.1002\/jat.3211"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hornberg, J.J., Laursen, M., Brenden, N., Persson, M., Thougaard, A.V., Toft, D.B. and Mow, T. (2014): Exploratory toxicology as an integrated part of drug discovery. Part I: why and how. Drug Discov. Today, <b>19<\/b>, 1131-1136.","DOI":"10.1016\/j.drudis.2013.12.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hrycay, E.G. and Bandiera, S.M. (2015): Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer. Adv. Pharmacol., <b>74<\/b>, 35-84.","DOI":"10.1016\/bs.apha.2015.03.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hu, W., Sorrentino, C., Denison, M.S., Kolaja, K. and Fielden, M.R. (2007): Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants <i>in vivo<\/i> and <i>in vitro.<\/i> Mol. Pharmacol., <b>71<\/b>, 1475-1486.","DOI":"10.1124\/mol.106.032748"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ito, S., Chen, C., Satoh, J., Yim, S. and Gonzalez, F.J. (2007): Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J. Clin. Invest., <b>117<\/b>, 1940-1950.","DOI":"10.1172\/JCI31647"},{"key":"19","doi-asserted-by":"crossref","unstructured":"J\u00f6nsson, M.E., Mattsson, A., Shaik, S. and Brunstr\u00f6m, B. (2016): Toxicity and cytochrome P450 1A mRNA induction by 6-formylindolo[3,2-<i>b<\/i>]carbazole (FICZ) in chicken and Japanese quail embryos. Comp. Biochem. Physiol. C Toxicol. Pharmacol., <b>179<\/b>, 125-136.","DOI":"10.1016\/j.cbpc.2015.09.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kou, Z. and Dai, W. (2021): Aryl hydrocarbon receptor: its roles in physiology. Biochem. Pharmacol., <b>185<\/b>, 114428.","DOI":"10.1016\/j.bcp.2021.114428"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kuroda, K., Tsuyumine, S. and Kodama, T. (2016): Direct Synthesis of a PDE4 Inhibitor by Using Pd\u2013Cu-Catalyzed C\u2013H\/C\u2013Br Coupling of Benzoxazole with a Heteroaryl Bromide. Org. Process Res. Dev., <b>20<\/b>, 1053-1058.","DOI":"10.1021\/acs.oprd.6b00106"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lamas, B., Natividad, J.M. and Sokol, H. (2018): Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol., <b>11<\/b>, 1024-1038.","DOI":"10.1038\/s41385-018-0019-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lang, D., Radtke, M. and Bairlein, M. (2019): Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans. Chem. Res. Toxicol., <b>32<\/b>, 1115-1122.","DOI":"10.1021\/acs.chemrestox.8b00413"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M.J., Gonzalez, F.J. and Xie, W. (2010): A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology, <b>139<\/b>, 653-663.","DOI":"10.1053\/j.gastro.2010.03.033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Lindell, M., Lang, M. and Lennern\u00e4s, H. (2003): Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver. Eur. J. Drug Metab. Pharmacokinet., <b>28<\/b>, 41-48.","DOI":"10.1007\/BF03190865"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Lu, P., Cai, X., Guo, Y., Xu, M., Tian, J., Locker, J. and Xie, W. (2019): Constitutive Activation of the Human Aryl Hydrocarbon Receptor in Mice Promotes Hepatocarcinogenesis Independent of Its Coactivator Gadd45b. Toxicol. Sci., <b>167<\/b>, 581-592.","DOI":"10.1093\/toxsci\/kfy263"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Maher, J.M., Dieter, M.Z., Aleksunes, L.M., Slitt, A.L., Guo, G., Tanaka, Y., Scheffer, G.L., Chan, J.Y., Manautou, J.E., Chen, Y., Dalton, T.P., Yamamoto, M. and Klaassen, C.D. (2007): Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology, <b>46<\/b>, 1597-1610.","DOI":"10.1002\/hep.21831"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Manzella, C.R., Ackerman, M., Singhal, M., Ticho, A.L., Ceh, J., Alrefai, W.A., Saksena, S., Dudeja, P.K. and Gill, R.K. (2020): Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands. Cell. Physiol. Biochem., <b>54<\/b>, 126-141.","DOI":"10.33594\/000000209"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Maronpot, R.R., Yoshizawa, K., Nyska, A., Harada, T., Flake, G., Mueller, G., Singh, B. and Ward, J.M. (2010): Hepatic enzyme induction: histopathology. Toxicol. Pathol., <b>38<\/b>, 776-795.","DOI":"10.1177\/0192623310373778"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Matsuzaka, Y., Hosaka, T., Ogaito, A., Yoshinari, K. and Uesawa, Y. (2020): Prediction Model of Aryl Hydrocarbon Receptor Activation by a Novel QSAR Approach, DeepSnap-Deep Learning. Molecules, <b>25<\/b>.","DOI":"10.3390\/molecules25061317"},{"key":"31","doi-asserted-by":"crossref","unstructured":"McGill, M.R. and Jaeschke, H. (2019): Animal models of drug-induced liver injury. Biochim. Biophys. Acta Mol. Basis Dis., <b>1865<\/b>, 1031-1039.","DOI":"10.1016\/j.bbadis.2018.08.037"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Mocarelli, P., Needham, L.L., Marocchi, A., Patterson, D.G. Jr., Brambilla, P., Gerthoux, P.M., Meazza, L. and Carreri, V. (1991): Serum concentrations of 2,3,7,8-tetrachlorodibenzo-<i>p<\/i>-dioxin and test results from selected residents of Seveso, Italy. J. Toxicol. Environ. Health, <b>32<\/b>, 357-366.","DOI":"10.1080\/15287399109531490"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L. and Schwarz, M. (2004): A constitutively active dioxin\/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res., <b>64<\/b>, 4707-4710.","DOI":"10.1158\/0008-5472.CAN-03-0875"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Mohammadi-Bardbori, A., Bengtsson, J., Rannug, U., Rannug, A. and Wincent, E. (2012): Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR). Chem. Res. Toxicol., <b>25<\/b>, 1878-1884.","DOI":"10.1021\/tx300169e"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Mohammadi-Bardbori, A., Bastan, F. and Akbarizadeh, A.R. (2017): The highly bioactive molecule and signal substance 6-formylindolo[3,2-<i>b<\/i>]carbazole (FICZ) plays bi-functional roles in cell growth and apoptosis <i>in vitro.<\/i> Arch. Toxicol., <b>91<\/b>, 3365-3372.","DOI":"10.1007\/s00204-017-1950-9"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Murray, I.A. and Perdew, G.H. (2017): Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis. Curr. Opin. Toxicol., <b>2<\/b>, 15-23.","DOI":"10.1016\/j.cotox.2017.01.003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Nguyen, L.P. and Bradfield, C.A. (2008): The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol., <b>21<\/b>, 102-116.","DOI":"10.1021\/tx7001965"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Oberg, M., Bergander, L., H\u00e5kansson, H., Rannug, U. and Rannug, A. (2005): Identification of the tryptophan photoproduct 6-formylindolo[3,2-<i>b<\/i>]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol. Sci., <b>85<\/b>, 935-943.","DOI":"10.1093\/toxsci\/kfi154"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Pazderova-Vejlupkov\u00e1, J., Luk\u00e1s, E., N\u0115mcova, M., P\u00edckov\u00e1, J. and Jir\u00e1sek, L. (1981): The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men. Arch. Environ. Health, <b>36<\/b>, 5-11.","DOI":"10.1080\/00039896.1981.10667598"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Piloiu, C. and Dumitrascu, D.L. (2021): Albendazole-Induced Liver Injury. Am. J. Ther., <b>28<\/b>, e335-e340.","DOI":"10.1097\/MJT.0000000000001341"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Pocchiari, F., Silano, V. and Zampieri, A. (1979): Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann. N. Y. Acad. Sci., <b>320<\/b>, 311-320.","DOI":"10.1111\/j.1749-6632.1979.tb56614.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Rannug, A. and Rannug, U. (1989): UV-irradiation of tryptophan gives rise to AHH-inducing compounds with very high affinity for the Ah receptor. Chemosphere, <b>18<\/b>, 1101-1106.","DOI":"10.1016\/0045-6535(89)90242-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Rannug, A. and Rannug, U. (2018): The tryptophan derivative 6-formylindolo[3,2-<i>b<\/i>]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation. Crit. Rev. Toxicol., <b>48<\/b>, 555-574.","DOI":"10.1080\/10408444.2018.1493086"},{"key":"44","doi-asserted-by":"publisher","unstructured":"Schiering, C., Wincent, E., Metidji, A., Iseppon, A., Li, Y., Potocnik, A.J., Omenetti, S., Henderson, C.J., Wolf, C.R., Nebert, D.W. and Stockinger, B. (2017): Feedback control of AHR signalling regulates intestinal immunity. Nature, <b>542<\/b>, 242-245.","DOI":"10.1038\/nature21080"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Shimizu, Y., Sasaki, T., Yonekawa, E., Yamazaki, H., Ogura, R., Watanabe, M., Hosaka, T., Shizu, R., Takeshita, J.I. and Yoshinari, K. (2021): Association of CYP1A1 and CYP1B1 inhibition in <i>in vitro<\/i> assays with drug-induced liver injury. J. Toxicol. Sci., <b>46<\/b>, 167-176.","DOI":"10.2131\/jts.46.167"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Smirnova, A., Wincent, E., Vikstr\u00f6m Bergander, L., Alsberg, T., Bergman, J., Rannug, A. and Rannug, U. (2016): Evidence for New Light-Independent Pathways for Generation of the Endogenous Aryl Hydrocarbon Receptor Agonist FICZ. Chem. Res. Toxicol., <b>29<\/b>, 75-86.","DOI":"10.1021\/acs.chemrestox.5b00416"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Stockinger, B., Di Meglio, P., Gialitakis, M. and Duarte, J.H. (2014): The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol., <b>32<\/b>, 403-432.","DOI":"10.1146\/annurev-immunol-032713-120245"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Tochitani, T., Toyosawa, K., Matsumoto, I., Kouchi, M., Michimae, Y., Koujitani, T., Funabashi, H. and Seki, T. (2011): Immunohistochemical and ultrastructural analyses of cytoplasmic blood plasma inclusions of rat hepatocytes. J. Toxicol. Pathol., <b>24<\/b>, 245-249.","DOI":"10.1293\/tox.24.245"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Usui, T., Mise, M., Hashizume, T., Yabuki, M. and Komuro, S. (2009): Evaluation of the potential for drug-induced liver injury based on <i>in vitro<\/i> covalent binding to human liver proteins. Drug Metab. Dispos., <b>37<\/b>, 2383-2392.","DOI":"10.1124\/dmd.109.028860"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Sasaki, T., Takeshita, J.I., Kushida, M., Shimizu, Y., Oki, H., Kitsunai, Y., Nakayama, H., Saruhashi, H., Ogura, R., Shizu, R., Hosaka, T. and Yoshinari, K. (2020): Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity. Toxicol. Appl. Pharmacol., <b>388<\/b>, 114854.","DOI":"10.1016\/j.taap.2019.114854"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Wei, Y.-D., Helleberg, H., Rannug, U. and Rannug, A. (1998): Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-<i>b<\/i>]carbazole. Chem. Biol. Interact., <b>110<\/b>, 39-55.","DOI":"10.1016\/S0009-2797(97)00111-7"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Wei, Y.-D., Rannug, U. and Rannug, A. (1999): UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan. Chem. Biol. Interact., <b>118<\/b>, 127-140.","DOI":"10.1016\/S0009-2797(98)00118-5"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Wei, Y.D., Bergander, L., Rannug, U. and Rannug, A. (2000): Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-<i>b<\/i>]carbazole. Arch. Biochem. Biophys., <b>383<\/b>, 99-107.","DOI":"10.1006\/abbi.2000.2037"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Westerink, W.M., Stevenson, J.C. and Schoonen, W.G. (2008): Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch. Toxicol., <b>82<\/b>, 909-921.","DOI":"10.1007\/s00204-008-0317-7"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A. and Rannug, U. (2009): The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-<i>b<\/i>]carbazole is present in humans. J. Biol. Chem., <b>284<\/b>, 2690-2696.","DOI":"10.1074\/jbc.M808321200"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Wincent, E., Bengtsson, J., Mohammadi Bardbori, A., Alsberg, T., Luecke, S., Rannug, U. and Rannug, A. (2012): Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA, <b>109<\/b>, 4479-4484.","DOI":"10.1073\/pnas.1118467109"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Wincent, E., Kubota, A., Timme-Laragy, A., J\u00f6nsson, M.E., Hahn, M.E. and Stegeman, J.J. (2016): Biological effects of 6-formylindolo[3,2-<i>b<\/i>]carbazole (FICZ) <i>in vivo<\/i> are enhanced by loss of CYP1A function in an Ahr2-dependent manner. Biochem. Pharmacol., <b>110-111<\/b>, 117-129.","DOI":"10.1016\/j.bcp.2016.04.012"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Woolf, T.F., Pool, W.F., Walker, R.M. and Monteith, D.K. (1996): Liver reactions to tacrine. In: Cameron, R.G., Feuer, G., de la Iglesia, F.A. (eds) Drug-Induced Hepatotoxicity. Handbook of Experimental Pharmacology, vol 121. Springer, Berlin, Heidelberg.","DOI":"10.1007\/978-3-642-61013-4_17"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Yamazoe, Y. and Yoshinari, K. (2020): Prediction of regioselectivity and preferred order of CYP1A1-mediated metabolism: solving the interaction of human and rat CYP1A1 forms with ligands on the template system. Drug Metab. Pharmacokinet., <b>35<\/b>, 165-185.","DOI":"10.1016\/j.dmpk.2019.10.008"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/9\/47_359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:57:16Z","timestamp":1715230636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/9\/47_359\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.47.359","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}